Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase I/II Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation
Study Type: Treatment
Phase: I/II
NCTID: NCT03785249
Principal Investigator:
Jun Zhang
A Randomized Phase II Study of Carboplatin and Pemetrexed with or without Selpercatinib LY3527723 in Participants with Non-Squamous RET Fusion-Positive Stage IV Non-Small Cell Lung Cancer and Progression of Disease on Prior RET Directed Therapy Lung-MAP Sub-Study NCT 05364645
Randomized Blinded Phase 3 Assessment of Second-or Third Line Chemotherapy with Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients with Advanced Non-Small Cell Lung Cancer with at Least 1 Large Lung Lesion,DUBLIN-3
Phase I/II Study of Stereotactic Body Radiation Therapy SBRT with or without GC4711 for Early Stage, Centrally Located or Large Non-Small Cell Lung Cancer NSCLC GRECO-1
Pivotal, Open-Label, Randomized Study Of Radiosurgery With Or Without Tumor Treating Fields TTFields For 1-10 Brain Metastases From Non-Small Cell Lung Cancer NSCLC.
A Multi-Center Phase II Study of Ipatasertib in Combination with Docetaxel in Metastatic/Advanced NSCLC Patients Who Have Failed or Are Intolerant to 1st Line Immunotherapy
Study Type: Treatment
Phase: II
NCTID: NCT04467801
Principal Investigator:
Jun Zhang
A Phase III, Controlled, Open-label, Randomized Study of RRx-001 Administered Sequentially with a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond Small Cell Carcinoma
Microbiome in immunotherapy na�ve NSCLC patients receiving PD-1/L1 blockade MIP_NSCLC
Study Type: Basic Science
Phase: IV
NCTID: NCT04636775
Principal Investigator:
Jun Zhang
A Phase II, Open-Label, Parallel Cohort Study Of Subcutaneous Amivantamab In Multiple Regimens In Patients With Advanced Or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer PALOMA-2
Study Type: Treatment
Phase: II
NCTID: NCT05498428
Principal Investigator:
Jun Zhang
A Phase I Dose Finding and Phase II Randomized Trial of Iadademstat Combined with Immune Checkpoint Inhibition Maintenance After Initial Chemoimmunotherapy in Patients with Extensive-Stage Small Cell Lung Cancer
Study Type: Treatment
Phase: I/II
NCTID: NCT06287775
Principal Investigator:
Chao Huang